-

Cutera Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO®

The Secret by Cutera® portfolio expands with the first combination 1540 nm laser and radio frequency microneedling technology available in the US.

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR) a global leader in aesthetic and dermatology solutions, today announces the launch of Secret DUO, an innovative skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications.

Optimized to treat varying layers of the skin, Secret DUO is equipped with a radio frequency microneedling (RFMN) handpiece along with a fractional non-ablative 1540 nm erbium glass laser. The unique pairing of these modalities allows practitioners to provide fully customizable solutions for fine lines, texture, pigment, stretchmarks, and scars.1,2

“A device with two clinically proven technologies that cater to all skin types is a huge benefit for my practice,” said Ashish Bhatia, MD, FAAD, Co-Director of Dermatologic, Laser and Cosmetic Surgery at Oak Dermatology, Naperville, IL.3 “The versatility and speed of Secret DUO are a big value add on top of the customizability. I’m excited to offer exclusive skin solutions that I know my patients are requesting.”

Secret DUO boasts quick treatment sessions along with optimized patient comfort from its RFMN smooth motor technology, selective energy delivery, and adjustable intensity. Practitioners can also take advantage of the device’s signature 1540 nm Secret Glow treatment that rapidly and effectively resurfaces skin to induce bulk collagen heating and remodeling with little to no downtime.1,2

“Cutera remains steadfast in our commitment to innovation, recognizing the need for devices that meet the demands of an evolving aesthetic landscape,” said Taylor Harris, CEO at Cutera. “With the launch of Secret DUO, we’re excited to deliver a technology that’s beneficial to both providers and their patients, with fast treatment times, unique modalities, and effective results.”

Secret DUO is now commercially available in the United States. Interested providers are encouraged to visit www.secretbycutera.com/en-us/providers/ for more information.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1 415-657-5500 or 1-888-4CUTERA or visit Cutera.com.

1 Via hemostasis and coagulation
2 Via skin resurfacing
3 Based on pre-commercial availability

Contacts

Media: EvolveMKD – Cutera@EvolveMKD.com

Investor Relations: Greg Barker, VP, FP&A and Investor Relations – IR@Cutera.com

Cutera, Inc.

NASDAQ:CUTR
Details
Headquarters: Brisbane, CA
CEO: Taylor Harris
Employees: 450
Organization: PUB
Revenues: $252 million (2022)
Net Income: NM (2022)

Release Versions

Contacts

Media: EvolveMKD – Cutera@EvolveMKD.com

Investor Relations: Greg Barker, VP, FP&A and Investor Relations – IR@Cutera.com

More News From Cutera, Inc.

Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financ...

Cutera Announces Voluntarily Delisting from Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be...

Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company’s notes, to strengthen its balance sheet and position Cutera for long-term success. Through the transaction, Cutera will reduce its debt by nearly $400 million, or over 90%, and raise $65 million in ne...
Back to Newsroom